May 7, 2008 - Research and Markets (http://www.researchandmarkets.com/reports/c90955) has announced the addition of CNS Generic Drugs: Prospects and Opportunities to 2012 to their offering.
One of the fastest growing drug sectors in terms of product and market value, CNS presents the generics industry with much needed on-going product opportunities
The major categories include antidepressants, schizophrenia, neurodegeneration, multiple sclerosis, ADHD and insomnia.
The details can be read here.
No comments:
Post a Comment